New data reveal that starting furoate/umeclidinium/vilanterol (FF/UMEC/VI) without delay not only significantly reduces exacerbations and health care costs but also enhances adherence and persistence for patients with chronic obstructive pulmonary disease (COPD) compared with other therapies.
A sounding rocket experiment set off a spectacular nighttime light show over Scandinavia as it produced new insights into ionospheric behavior near an aurora.